Comparison of tolerance to morphine-induced respiratory and analgesic effects in mice

Wasseem Mohammed1, Hisham Alhaddad, Nicolas Marie

  • 1Neuropsychopharmacologie des Addictions, Faculté de Pharmacie, Université Paris-Descartes, Paris, France.

Toxicology Letters
|January 9, 2013
PubMed

Insights

Chronic morphine use leads to weaker tolerance for respiratory effects than pain relief. This study in mice reveals differing tolerance mechanisms, with brainstem and periaqueductal gray (PAG) adenylate cyclase (AC) activity playing a key role.

Area of Science:

  • Pharmacology
  • Neuroscience

Background:

  • Chronic morphine administration can lead to severe poisoning.
  • Tolerance to morphine's analgesic effects may differ from tolerance to its respiratory effects.

Purpose of the Study:

  • To compare the development of tolerance to morphine's analgesic and respiratory effects in mice.
  • To investigate the underlying mechanisms, focusing on mu-opioid receptors (MOR) and adenylate cyclase (AC) activity in the periaqueductal gray (PAG) and brainstem.

Main Methods:

  • Tolerance assessed via hot plate test for analgesia and plethysmography for respiratory effects.
  • Mechanisms investigated using MOR binding studies and AC activity assays in brain tissue homogenates.
  • Experiments conducted in mice using varying morphine doses and administration schedules.

Main Results:

  • Repeated morphine administration resulted in a 13-fold increase in analgesic ED₅₀, versus a 2-4 fold increase for respiratory effects.
  • No significant changes in MOR expression were found in the PAG or brainstem.
  • Superactivation of AC was observed in the PAG, but not the brainstem, of morphine-treated mice.

Conclusions:

  • Tolerance to morphine's respiratory effects is significantly less developed than tolerance to its analgesic effects in mice.
  • Differential AC activation in the PAG compared to the brainstem contributes to the observed disparities in morphine tolerance.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...